Cannom D S
Division of Cardiology, Good Samaritan Hospital, Los Angeles, California, USA.
Am J Cardiol. 2000 May 25;85(10A):25D-35D. doi: 10.1016/s0002-9149(00)00904-8.
Various nonpharmacologic interventions are available for patients with atrial fibrillation (AF) who are refractory to standard drug therapy. Atrioventricular junctional ablation and permanent pacing is a very effective therapy for patients with AF and a poorly controlled ventricular response. The surgical MAZE procedure has been performed on small numbers of patients but is remarkably successful in restoring and maintaining sinus rhythm. The role of permanent pacing as treatment for paroxysmal AF is undergoing evaluation and dual-site atrial pacing appears particularly promising in reducing the number of episodes of paroxysmal AF. Certainly the most exciting frontier in the treatment of AF is radiofrequency catheter ablation procedures. Our understanding of the mechanisms of paroxysmal AF and chronic AF has expanded enormously in the past 5 years. Radiofrequency lesions in pulmonary veins using standard technology will cure many cases of paroxysmal AF. However, catheter systems under development offer a great promise of treating most paroxysmal and chronic AF within the next few years. These developments will revolutionize our approach to this ever more prevalent clinical problem.
对于那些对标准药物治疗无效的心房颤动(AF)患者,有多种非药物干预措施可供选择。房室结消融和永久起搏对于AF患者且心室反应控制不佳的情况是一种非常有效的治疗方法。外科迷宫手术已在少数患者中实施,并且在恢复和维持窦性心律方面非常成功。永久起搏作为阵发性AF治疗方法的作用正在接受评估,双部位心房起搏在减少阵发性AF发作次数方面似乎特别有前景。当然,AF治疗中最令人兴奋的前沿领域是射频导管消融手术。在过去5年中,我们对阵发性AF和慢性AF机制的理解有了极大的扩展。使用标准技术在肺静脉中进行射频消融可治愈许多阵发性AF病例。然而,正在研发的导管系统有望在未来几年内治疗大多数阵发性和慢性AF。这些进展将彻底改变我们处理这个日益普遍的临床问题的方法。